Take Control of Your Cancer Journey with Advanced PD-L1 Monitoring
Facing cancer treatment can feel overwhelming, especially when you’re unsure if your therapy is working effectively. The uncertainty about treatment response and potential recurrence can create significant anxiety. At Oracle Genomics, we understand these concerns and offer the OncoPro PD-L1 Circulating Tumor Cells Test – a revolutionary approach that provides clarity and confidence throughout your cancer treatment journey.
Understanding Your PD-L1 Circulating Tumor Cells Test
This advanced liquid biopsy test detects PD-L1 expressing circulating tumor cells in your bloodstream. Unlike traditional tissue biopsies that require invasive procedures, this test uses a simple blood draw to monitor your cancer’s behaviour and response to immunotherapy treatments. PD-L1 is a protein that cancer cells sometimes use to hide from your immune system, and detecting these cells helps determine if immunotherapy is the right approach for your specific cancer type.
Who Should Consider This Important Test?
This test is particularly valuable for:
- Patients currently undergoing or considering immunotherapy treatment
- Individuals with cancers known to respond to immunotherapy (lung cancer, melanoma, bladder cancer, etc.)
- Patients wanting to monitor treatment effectiveness without repeated invasive biopsies
- Those concerned about cancer recurrence who want proactive monitoring
- Patients whose previous tissue biopsies were insufficient for PD-L1 testing
If you’re experiencing uncertainty about your treatment’s effectiveness or worrying about recurrence, this test provides the answers you need for peace of mind.
Why This Test Matters for Your Cancer Journey
The OncoPro PD-L1 test offers multiple life-changing benefits:
- Personalised Treatment Decisions: Helps your oncologist determine the most effective immunotherapy approach
- Early Detection of Resistance: Identifies when cancer cells may be developing resistance to treatment
- Non-Invasive Monitoring: Avoids the discomfort and risks of repeated tissue biopsies
- Proactive Recurrence Detection: Provides early warning of potential cancer return
- Treatment Optimisation: Ensures you’re receiving the most appropriate therapy for your specific cancer
Many patients find this test brings tremendous relief by replacing uncertainty with clear, actionable information.
Understanding Your Test Results with Confidence
Your results will clearly indicate the presence and quantity of PD-L1 expressing circulating tumor cells. Our comprehensive report includes:
- Clear interpretation of PD-L1 expression levels
- Contextual information about what the results mean for your treatment
- Guidance for discussing results with your oncologist
- Recommendations for next steps based on your specific situation
We provide detailed explanations in plain language, ensuring you fully understand your results and their implications for your treatment plan. Your oncologist will use this information to make informed decisions about continuing, modifying, or changing your therapy.
Transparent Pricing & Exceptional Value
| Service | Regular Price | Special Price | Turnaround Time |
|---|---|---|---|
| OncoPro PD-L1 Circulating Tumor Cells Test | ZAR 17,550 | 21 Working Days |
Consider this investment in your health: early detection of treatment resistance or recurrence can save significantly on future medical costs and, most importantly, preserve your quality of life.
Why Trust Oracle Genomics with Your Cancer Monitoring?
We’ve built our reputation on accuracy, reliability, and patient care:
- Nationwide Coverage: Accessible testing centres across Johannesburg, Cape Town, Durban, and Pretoria
- Expert Analysis: Specialised oncology testing with rigorous quality control
- Patient-Focused Approach: Clear communication and compassionate support throughout your journey
- Advanced Technology: State-of-the-art laboratory equipment ensuring precise results
- Medical Collaboration: Seamless integration with your existing healthcare team
Our commitment to accuracy means you can make treatment decisions with complete confidence.
Simple Sample Collection Process
We’ve made the testing process as straightforward as possible:
- 8 mL whole blood collection in provided lavender top EDTA tube
- Add preservative using supplied syringe and needle
- Ship immediately at 18-22°C (DO NOT refrigerate or freeze)
- Complete OncoPro Liquid Biopsy Clinical Information Form (Form 32)
Our team provides clear instructions and support throughout the collection process.
Take the Next Step Toward Treatment Clarity
Don’t let uncertainty about your cancer treatment create unnecessary stress. The OncoPro PD-L1 test provides the clarity you need to move forward with confidence.
Limited Time Offer: Book within the next 7 days to secure the special price of ZAR 17,550 (regularly ZAR 19,500). Take control of your cancer journey today.
Nationwide Accessibility for South African Patients
We believe advanced cancer monitoring should be accessible to all South Africans. Our services extend across major centres including Johannesburg, Cape Town, Durban, Pretoria, and surrounding areas. Wherever you are in South Africa, we’re committed to bringing world-class cancer monitoring to your community.
